ReviewExpert review of hematology2021

An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.

Tamer A Othman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.